1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Cytosine	_	_	NN	_	_	_	_	_
2	DNA	_	_	NN	_	_	_	_	_
3	methylation	_	_	NN	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	5-methylcytosine	_	_	NN	_	_	_	_	_
6	;	_	_	:	_	_	_	_	_
7	5mC	_	_	NNP	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	CDM	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	one	_	_	CD	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	most	_	_	RBS	_	_	_	_	_
16	well-studied	_	_	JJ	_	_	_	_	_
17	epigenomic	_	_	JJ	_	_	_	_	_
18	marks	_	_	NNS	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	mechanistically	_	_	RB	_	_	_	_	_
21	understood	_	_	VBN	_	_	_	_	_
22	epigenetic	_	_	JJ	_	_	_	_	_
23	modifications	_	_	NNS	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	date	_	_	VB	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	plays	_	_	VBZ	_	_	_	_	_
3	important	_	_	JJ	_	_	_	_	_
4	roles	_	_	NNS	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	various	_	_	JJ	_	_	_	_	_
7	biological	_	_	JJ	_	_	_	_	_
8	processes	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	including	_	_	VBG	_	_	_	_	_
11	X-chromosome	_	_	NN	_	_	_	_	_
12	inactivation	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	genomic	_	_	JJ	_	_	_	_	_
15	imprinting	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	transposon	_	_	NN	_	_	_	_	_
18	suppression	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	transcriptional	_	_	JJ	_	_	_	_	_
21	regulation	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Technological	_	_	JJ	_	_	_	_	_
2	improvements	_	_	NNS	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	dramatic	_	_	JJ	_	_	_	_	_
5	cost	_	_	NN	_	_	_	_	_
6	reductions	_	_	NNS	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	whole-genome	_	_	JJ	_	_	_	_	_
9	sodium	_	_	NN	_	_	_	_	_
10	bisulfite	_	_	NN	_	_	_	_	_
11	sequencing	_	_	NN	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	WGBS	_	_	NNP	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	DNA	_	_	NNP	_	_	_	_	_
17	have	_	_	VBP	_	_	_	_	_
18	opened	_	_	VBN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	door	_	_	NN	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	quantitative	_	_	JJ	_	_	_	_	_
24	measurement	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	DNA	_	_	NN	_	_	_	_	_
27	methylation	_	_	NN	_	_	_	_	_
28	at	_	_	IN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	single	_	_	JJ	_	_	_	_	_
31	base	_	_	NN	_	_	_	_	_
32	resolution	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	with	_	_	IN	_	_	_	_	_
35	datasets	_	_	NNS	_	_	_	_	_
36	now	_	_	RB	_	_	_	_	_
37	available	_	_	JJ	_	_	_	_	_
38	from	_	_	IN	_	_	_	_	_
39	numerous	_	_	JJ	_	_	_	_	_
40	species	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	humans	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	significant	_	_	JJ	_	_	_	_	_
5	methylation	_	_	NN	_	_	_	_	_
6	differences	_	_	NNS	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	observed	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	white	_	_	JJ	_	_	_	_	_
12	blood	_	_	NN	_	_	_	_	_
13	cells	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	matched	_	_	VBN	_	_	_	_	_
16	monozygotic	_	_	JJ	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	dizygotic	_	_	JJ	_	_	_	_	_
19	twins	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	significant	_	_	JJ	_	_	_	_	_
23	intra-	_	_	JJ	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	inter-population	_	_	NN	_	_	_	_	_
26	differential	_	_	JJ	_	_	_	_	_
27	methylation	_	_	NN	_	_	_	_	_
28	has	_	_	VBZ	_	_	_	_	_
29	been	_	_	VBN	_	_	_	_	_
30	identified	_	_	VBN	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	a	_	_	DT	_	_	_	_	_
33	study	_	_	NN	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	three	_	_	CD	_	_	_	_	_
36	human	_	_	JJ	_	_	_	_	_
37	populations	_	_	NNS	_	_	_	_	_
38	(	_	_	-LRB-	_	_	_	_	_
39	Caucasian-American	_	_	JJ	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	African-American	_	_	JJ	_	_	_	_	_
42	and	_	_	CC	_	_	_	_	_
43	Chinese-American	_	_	JJ	_	_	_	_	_
44	)	_	_	-RRB-	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	Likewise	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	DNA	_	_	NN	_	_	_	_	_
4	methylation	_	_	NN	_	_	_	_	_
5	levels	_	_	NNS	_	_	_	_	_
6	vary	_	_	VBP	_	_	_	_	_
7	considerably	_	_	RB	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	samples	_	_	NNS	_	_	_	_	_
10	experiencing	_	_	VBG	_	_	_	_	_
11	changes	_	_	NNS	_	_	_	_	_
12	during	_	_	IN	_	_	_	_	_
13	development	_	_	NN	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	response	_	_	NN	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	environmental	_	_	JJ	_	_	_	_	_
19	change	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Translation	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	advances	_	_	NNS	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	DNA	_	_	NN	_	_	_	_	_
7	methylation	_	_	NN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	clinical	_	_	JJ	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	personalized	_	_	VBN	_	_	_	_	_
12	medical	_	_	JJ	_	_	_	_	_
13	contexts	_	_	NNS	_	_	_	_	_
14	has	_	_	VBZ	_	_	_	_	_
15	been	_	_	VBN	_	_	_	_	_
16	proposed	_	_	VBN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Evidence	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	epigenetic	_	_	JJ	_	_	_	_	_
4	alterations	_	_	NNS	_	_	_	_	_
5	induced	_	_	VBN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	disease	_	_	NN	_	_	_	_	_
8	emphasizes	_	_	VBZ	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	significant	_	_	JJ	_	_	_	_	_
11	potential	_	_	JJ	_	_	_	_	_
12	value	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	high-resolution	_	_	JJ	_	_	_	_	_
15	methylation	_	_	NN	_	_	_	_	_
16	pattern	_	_	NN	_	_	_	_	_
17	analysis	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	proper	_	_	JJ	_	_	_	_	_
4	translation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	this	_	_	DT	_	_	_	_	_
7	knowledge	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	diagnostics	_	_	NN	_	_	_	_	_
10	depends	_	_	VBZ	_	_	_	_	_
11	upon	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	development	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	genome-wide	_	_	JJ	_	_	_	_	_
16	techniques	_	_	NNS	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	rapid	_	_	JJ	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	robust	_	_	JJ	_	_	_	_	_
22	identification	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	specific	_	_	JJ	_	_	_	_	_
25	epigenetic	_	_	JJ	_	_	_	_	_
26	alterations	_	_	NNS	_	_	_	_	_
27	associated	_	_	VBN	_	_	_	_	_
28	with	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	disease	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Currently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	numerous	_	_	JJ	_	_	_	_	_
6	available	_	_	JJ	_	_	_	_	_
7	bioinformatics	_	_	NN	_	_	_	_	_
8	tools	_	_	NNS	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	estimate	_	_	VB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	methylation	_	_	NN	_	_	_	_	_
13	status	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	nearly	_	_	RB	_	_	_	_	_
16	every	_	_	DT	_	_	_	_	_
17	cytosine	_	_	NN	_	_	_	_	_
18	position	_	_	NN	_	_	_	_	_
19	within	_	_	IN	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	whole-genome	_	_	JJ	_	_	_	_	_
22	bisulfite	_	_	NN	_	_	_	_	_
23	sequencing	_	_	NN	_	_	_	_	_
24	dataset	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	tools	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	generally	_	_	RB	_	_	_	_	_
5	supported	_	_	VBN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	an	_	_	DT	_	_	_	_	_
8	application	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	robust	_	_	JJ	_	_	_	_	_
11	statistical	_	_	JJ	_	_	_	_	_
12	approaches	_	_	NNS	_	_	_	_	_
13	;	_	_	:	_	_	_	_	_
14	DSS	_	_	NNP	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	BiSeq	_	_	NNP	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	methylKit	_	_	NNP	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	among	_	_	IN	_	_	_	_	_
22	others	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	are	_	_	VBP	_	_	_	_	_
25	ones	_	_	NNS	_	_	_	_	_
26	that	_	_	WDT	_	_	_	_	_
27	apply	_	_	VBP	_	_	_	_	_
28	generalized	_	_	VBN	_	_	_	_	_
29	linear	_	_	JJ	_	_	_	_	_
30	regression	_	_	NN	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_
32	beta-regression	_	_	NN	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	estimation	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	differentially	_	_	RB	_	_	_	_	_
39	methylated	_	_	VBN	_	_	_	_	_
40	positions	_	_	NNS	_	_	_	_	_
41	(	_	_	-LRB-	_	_	_	_	_
42	DMPs	_	_	NNS	_	_	_	_	_
43	)	_	_	-RRB-	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	methylKit	_	_	NNP	_	_	_	_	_
5	provides	_	_	VBZ	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	option	_	_	NN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	apply	_	_	VB	_	_	_	_	_
10	Fisher	_	_	NNP	_	_	_	_	_
11	â€™s	_	_	POS	_	_	_	_	_
12	exact	_	_	JJ	_	_	_	_	_
13	test	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Alternatively	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	methylpy	_	_	NN	_	_	_	_	_
4	bases	_	_	VBZ	_	_	_	_	_
5	its	_	_	PRP$	_	_	_	_	_
6	estimation	_	_	NN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	implementation	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	root-mean-square	_	_	JJ	_	_	_	_	_
13	test	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	RMST	_	_	NN	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	approaches	_	_	NNS	_	_	_	_	_
5	do	_	_	VBP	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	incorporate	_	_	VB	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	influence	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	natural	_	_	JJ	_	_	_	_	_
12	stochasticity	_	_	NN	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	randomness	_	_	NN	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	their	_	_	PRP$	_	_	_	_	_
18	models	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	limiting	_	_	VBG	_	_	_	_	_
21	their	_	_	PRP$	_	_	_	_	_
22	resolution	_	_	NN	_	_	_	_	_
23	predominantly	_	_	RB	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	genomic	_	_	JJ	_	_	_	_	_
26	regions	_	_	NNS	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	highest	_	_	JJS	_	_	_	_	_
30	probability	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	having	_	_	VBG	_	_	_	_	_
33	undergone	_	_	VBN	_	_	_	_	_
34	a	_	_	DT	_	_	_	_	_
35	methylation	_	_	NN	_	_	_	_	_
36	change	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	consequence	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	these	_	_	DT	_	_	_	_	_
6	approaches	_	_	NNS	_	_	_	_	_
7	do	_	_	VBP	_	_	_	_	_
8	not	_	_	RB	_	_	_	_	_
9	have	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	ability	_	_	NN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	distinguish	_	_	VB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	DMP	_	_	NN	_	_	_	_	_
16	signal	_	_	NN	_	_	_	_	_
17	associated	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	specific	_	_	JJ	_	_	_	_	_
21	treatment	_	_	NN	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	disease	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	from	_	_	IN	_	_	_	_	_
27	DMPs	_	_	NNS	_	_	_	_	_
28	deriving	_	_	VBG	_	_	_	_	_
29	from	_	_	IN	_	_	_	_	_
30	natural	_	_	JJ	_	_	_	_	_
31	variation	_	_	NN	_	_	_	_	_
32	within	_	_	IN	_	_	_	_	_
33	control	_	_	NN	_	_	_	_	_
34	(	_	_	-LRB-	_	_	_	_	_
35	or	_	_	CC	_	_	_	_	_
36	heathy	_	_	JJ	_	_	_	_	_
37	)	_	_	-RRB-	_	_	_	_	_
38	individuals	_	_	NNS	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	and	_	_	CC	_	_	_	_	_
41	are	_	_	VBP	_	_	_	_	_
42	thus	_	_	RB	_	_	_	_	_
43	not	_	_	RB	_	_	_	_	_
44	suitable	_	_	JJ	_	_	_	_	_
45	for	_	_	IN	_	_	_	_	_
46	clinical	_	_	JJ	_	_	_	_	_
47	diagnostics	_	_	NNS	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	suggest	_	_	VBP	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	methylation	_	_	NN	_	_	_	_	_
5	variation	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	diagnostics	_	_	NN	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	essentially	_	_	RB	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	signal	_	_	NN	_	_	_	_	_
12	detection	_	_	NN	_	_	_	_	_
13	problem	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	equivalent	_	_	JJ	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	binary	_	_	JJ	_	_	_	_	_
19	classification	_	_	NN	_	_	_	_	_
20	problem	_	_	NN	_	_	_	_	_
21	for	_	_	IN	_	_	_	_	_
22	discriminating	_	_	VBG	_	_	_	_	_
23	healthy	_	_	JJ	_	_	_	_	_
24	versus	_	_	IN	_	_	_	_	_
25	diseased	_	_	VBN	_	_	_	_	_
26	individuals	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Signal	_	_	NN	_	_	_	_	_
2	detection	_	_	NN	_	_	_	_	_
3	theory	_	_	NN	_	_	_	_	_
4	provides	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	methodological	_	_	JJ	_	_	_	_	_
7	framework	_	_	NN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	address	_	_	VB	_	_	_	_	_
10	this	_	_	DT	_	_	_	_	_
11	type	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	detection	_	_	NN	_	_	_	_	_
14	problem	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	evidenced	_	_	VBN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	its	_	_	PRP$	_	_	_	_	_
19	common	_	_	JJ	_	_	_	_	_
20	application	_	_	NN	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	clinical	_	_	JJ	_	_	_	_	_
23	diagnostic	_	_	JJ	_	_	_	_	_
24	tests	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	machine-learning	_	_	NN	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	ML	_	_	NN	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	approaches	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	human	_	_	JJ	_	_	_	_	_
34	communication	_	_	NN	_	_	_	_	_
35	technologies	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	probability	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	extreme	_	_	JJ	_	_	_	_	_
5	methylation	_	_	NN	_	_	_	_	_
6	changes	_	_	NNS	_	_	_	_	_
7	occurring	_	_	VBG	_	_	_	_	_
8	spontaneously	_	_	RB	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	control	_	_	NN	_	_	_	_	_
12	group	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	samples	_	_	NNS	_	_	_	_	_
15	by	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	stochastic	_	_	JJ	_	_	_	_	_
18	fluctuations	_	_	NNS	_	_	_	_	_
19	inherent	_	_	JJ	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	biochemical	_	_	JJ	_	_	_	_	_
22	processes	_	_	NNS	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	DNA	_	_	NN	_	_	_	_	_
25	maintenance	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	requires	_	_	VBZ	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	discrimination	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	this	_	_	DT	_	_	_	_	_
32	background	_	_	NN	_	_	_	_	_
33	variation	_	_	NN	_	_	_	_	_
34	from	_	_	IN	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	biological	_	_	JJ	_	_	_	_	_
37	treatment	_	_	NN	_	_	_	_	_
38	signal	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Regardless	_	_	RB	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	environmental	_	_	JJ	_	_	_	_	_
4	constancy	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	statistically	_	_	RB	_	_	_	_	_
7	significant	_	_	JJ	_	_	_	_	_
8	methylation	_	_	NN	_	_	_	_	_
9	changes	_	_	NNS	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	found	_	_	VBN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	control	_	_	NN	_	_	_	_	_
14	populations	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	probability	_	_	NN	_	_	_	_	_
17	greater	_	_	JJR	_	_	_	_	_
18	than	_	_	IN	_	_	_	_	_
19	zero	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	system	_	_	NN	_	_	_	_	_
3	fluctuations	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	inherent	_	_	JJ	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	biological	_	_	JJ	_	_	_	_	_
8	stochastic	_	_	JJ	_	_	_	_	_
9	processes	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	comprise	_	_	VBP	_	_	_	_	_
12	natural	_	_	JJ	_	_	_	_	_
13	background	_	_	NN	_	_	_	_	_
14	variation	_	_	NN	_	_	_	_	_
15	detected	_	_	VBN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	human	_	_	JJ	_	_	_	_	_
18	methylomes	_	_	NNS	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	By	_	_	IN	_	_	_	_	_
2	simulation	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	it	_	_	PRP	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	feasible	_	_	JJ	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	demonstrate	_	_	VB	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	DMPs	_	_	NNS	_	_	_	_	_
11	spontaneously	_	_	RB	_	_	_	_	_
12	arise	_	_	VBP	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	control	_	_	NN	_	_	_	_	_
15	populations	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	that	_	_	IN	_	_	_	_	_
19	regulatory	_	_	JJ	_	_	_	_	_
20	methylation	_	_	NN	_	_	_	_	_
21	signals	_	_	NNS	_	_	_	_	_
22	also	_	_	RB	_	_	_	_	_
23	occur	_	_	VB	_	_	_	_	_
24	naturally	_	_	RB	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	control	_	_	NN	_	_	_	_	_
28	group	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Stochastic	_	_	JJ	_	_	_	_	_
2	fluctuation	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	methylation	_	_	NN	_	_	_	_	_
6	process	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	expected	_	_	VBN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	since	_	_	IN	_	_	_	_	_
11	methylation	_	_	NN	_	_	_	_	_
12	regulatory	_	_	JJ	_	_	_	_	_
13	machinery	_	_	NN	_	_	_	_	_
14	participates	_	_	VBZ	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	not	_	_	RB	_	_	_	_	_
17	only	_	_	RB	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	organismal	_	_	JJ	_	_	_	_	_
20	adaptation	_	_	NN	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	micro-	_	_	JJ	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	macro-environmental	_	_	JJ	_	_	_	_	_
25	fluctuations	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	but	_	_	CC	_	_	_	_	_
28	also	_	_	RB	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	transitions	_	_	NNS	_	_	_	_	_
31	across	_	_	IN	_	_	_	_	_
32	different	_	_	JJ	_	_	_	_	_
33	stages	_	_	NNS	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	organismal	_	_	JJ	_	_	_	_	_
36	ontogenetic	_	_	JJ	_	_	_	_	_
37	development	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	variation	_	_	NN	_	_	_	_	_
3	must	_	_	MD	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	factored	_	_	VBN	_	_	_	_	_
6	into	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	construction	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	methylation	_	_	NN	_	_	_	_	_
12	pipeline	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	be	_	_	VB	_	_	_	_	_
15	used	_	_	VBN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	clinical	_	_	JJ	_	_	_	_	_
18	diagnostics	_	_	NNS	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	need	_	_	NN	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	application	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	signal	_	_	NN	_	_	_	_	_
8	detection-based	_	_	JJ	_	_	_	_	_
9	approaches	_	_	NNS	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	diagnostics	_	_	NNS	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	pointed	_	_	VBN	_	_	_	_	_
14	out	_	_	RP	_	_	_	_	_
15	decades	_	_	NNS	_	_	_	_	_
16	ago	_	_	RB	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	standard	_	_	JJ	_	_	_	_	_
21	practice	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	current	_	_	JJ	_	_	_	_	_
24	implementations	_	_	NNS	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	clinical	_	_	JJ	_	_	_	_	_
27	diagnostic	_	_	JJ	_	_	_	_	_
28	tests	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Detection	_	_	NN	_	_	_	_	_
2	approaches	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	default	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	included	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	machine/statistical	_	_	JJ	_	_	_	_	_
11	learning	_	_	NN	_	_	_	_	_
12	implementations	_	_	NNS	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	classification	_	_	NN	_	_	_	_	_
15	tasks	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	since	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	evaluation	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	classifier	_	_	NN	_	_	_	_	_
22	performance	_	_	NN	_	_	_	_	_
23	is	_	_	VBZ	_	_	_	_	_
24	basically	_	_	RB	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	detection	_	_	NN	_	_	_	_	_
27	problem	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	determination	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	optimal	_	_	JJ	_	_	_	_	_
8	cutoff	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	threshold	_	_	NN	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	value	_	_	NN	_	_	_	_	_
13	at	_	_	IN	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	signal	_	_	NN	_	_	_	_	_
16	can	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	discriminated	_	_	VBN	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	noise	_	_	NN	_	_	_	_	_
21	at	_	_	IN	_	_	_	_	_
22	an	_	_	DT	_	_	_	_	_
23	acceptable	_	_	JJ	_	_	_	_	_
24	signal-to-noise	_	_	JJ	_	_	_	_	_
25	ratio	_	_	NN	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	i.	_	_	FW	_	_	_	_	_
28	e.	_	_	FW	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	maximum	_	_	JJ	_	_	_	_	_
31	accuracy	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	sensitivity	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	lowest	_	_	JJS	_	_	_	_	_
36	false	_	_	JJ	_	_	_	_	_
37	discovery	_	_	NN	_	_	_	_	_
38	rate	_	_	NN	_	_	_	_	_
39	(	_	_	-LRB-	_	_	_	_	_
40	FDR	_	_	NNP	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	)	_	_	-RRB-	_	_	_	_	_
43	is	_	_	VBZ	_	_	_	_	_
44	equivalent	_	_	JJ	_	_	_	_	_
45	to	_	_	TO	_	_	_	_	_
46	a	_	_	DT	_	_	_	_	_
47	classification	_	_	NN	_	_	_	_	_
48	problem	_	_	NN	_	_	_	_	_
49	,	_	_	,	_	_	_	_	_
50	a	_	_	DT	_	_	_	_	_
51	direct	_	_	JJ	_	_	_	_	_
52	corollary	_	_	NN	_	_	_	_	_
53	to	_	_	TO	_	_	_	_	_
54	diagnostic	_	_	JJ	_	_	_	_	_
55	detection	_	_	NN	_	_	_	_	_
56	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	natural	_	_	JJ	_	_	_	_	_
3	spontaneous	_	_	JJ	_	_	_	_	_
4	variation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	DNA	_	_	NN	_	_	_	_	_
7	methylation	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	human	_	_	JJ	_	_	_	_	_
10	populations	_	_	NNS	_	_	_	_	_
11	complicates	_	_	VBZ	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	discrimination	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	methylation	_	_	NN	_	_	_	_	_
17	signal	_	_	NN	_	_	_	_	_
18	from	_	_	IN	_	_	_	_	_
19	background	_	_	NN	_	_	_	_	_
20	variation	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	address	_	_	VBP	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	issue	_	_	NN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	determining	_	_	VBG	_	_	_	_	_
7	whether	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	given	_	_	VBN	_	_	_	_	_
10	DMP	_	_	NN	_	_	_	_	_
11	detected	_	_	VBN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	treatment/patient	_	_	JJ	_	_	_	_	_
15	population	_	_	NN	_	_	_	_	_
16	occurs	_	_	VBZ	_	_	_	_	_
17	within	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	control	_	_	NN	_	_	_	_	_
20	population	_	_	NN	_	_	_	_	_
21	as	_	_	RB	_	_	_	_	_
22	well	_	_	RB	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	probability	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	observing	_	_	VBG	_	_	_	_	_
29	it	_	_	PRP	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	focus	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	identification	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	DMPs	_	_	NNPS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	but	_	_	CC	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	whether	_	_	IN	_	_	_	_	_
16	these	_	_	DT	_	_	_	_	_
17	statistically	_	_	RB	_	_	_	_	_
18	significant	_	_	JJ	_	_	_	_	_
19	changes	_	_	NNS	_	_	_	_	_
20	occur	_	_	VBP	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	high	_	_	JJ	_	_	_	_	_
23	probability	_	_	NN	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	under	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	fixed	_	_	VBN	_	_	_	_	_
28	experimental	_	_	JJ	_	_	_	_	_
29	conditions	_	_	NNS	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	only	_	_	RB	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	treatment	_	_	NN	_	_	_	_	_
35	group	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	we	_	_	PRP	_	_	_	_	_
3	address	_	_	VBP	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	problem	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	context	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	signal	_	_	NN	_	_	_	_	_
11	detection	_	_	NN	_	_	_	_	_
12	theory	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	ML	_	_	NN	_	_	_	_	_
15	frameworks	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	illustrate	_	_	VB	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	feasibility	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	our	_	_	PRP$	_	_	_	_	_
7	proposed	_	_	VBN	_	_	_	_	_
8	approach	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	clinical	_	_	JJ	_	_	_	_	_
11	diagnostics	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	results	_	_	NNS	_	_	_	_	_
14	from	_	_	IN	_	_	_	_	_
15	simulation	_	_	NN	_	_	_	_	_
16	studies	_	_	NNS	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	tests	_	_	NNS	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	two	_	_	CD	_	_	_	_	_
21	available	_	_	JJ	_	_	_	_	_
22	methylome	_	_	NN	_	_	_	_	_
23	datasets	_	_	NNS	_	_	_	_	_
24	from	_	_	IN	_	_	_	_	_
25	leukemia	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	autism	_	_	NN	_	_	_	_	_
28	patients	_	_	NNS	_	_	_	_	_
29	are	_	_	VBP	_	_	_	_	_
30	presented	_	_	VBN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	discussed	_	_	VBN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	approach	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	implemented	_	_	VBN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	R	_	_	NNP	_	_	_	_	_
8	package	_	_	NN	_	_	_	_	_
9	Methyl-IT	_	_	NNP	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	available	_	_	JJ	_	_	_	_	_
12	at	_	_	IN	_	_	_	_	_
13	GitHub	_	_	NNP	_	_	_	_	_
14	:	_	_	:	_	_	_	_	_
15	https://github.com/genomaths/MethylIT	_	_	NNP	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	R	_	_	NNP	_	_	_	_	_
3	scripts	_	_	NNS	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	reproduce	_	_	VB	_	_	_	_	_
6	these	_	_	DT	_	_	_	_	_
7	analyses	_	_	NNS	_	_	_	_	_
8	are	_	_	VBP	_	_	_	_	_
9	available	_	_	JJ	_	_	_	_	_
10	at	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	PSU	_	_	NNP	_	_	_	_	_
13	GitLab	_	_	NNP	_	_	_	_	_
14	:	_	_	:	_	_	_	_	_
15	https://git.psu.edu/genomath/MethylIT_examples	_	_	NNP	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_

